|
|
|
|
|
|
by tpm
2931 days ago
|
|
|
Those are pilot studies. There is one psilocybin study by Compass Pathways starting this year in 8 EU countries with I think about 800 participants which if successful will pave the way for legal use of psilocybin therapy of depression. MAPS is doing another one for MDMA for PTSD, that's FDA Phase 3 in 14 international sites. |
|
|